[Evaluation of subcutaneous-lead implantable cardioverter-defibrillators]
Collette C
Record ID 32017000017
French
Authors' recommendations:
Based on the present review of the scientific literature, INESSS concludes that:
- the S-ICD is a promising technology that provides the option of a defibrillator to certain specific patient populations for whom the TV-ICD is contraindicated;
- the S-ICD is an innovative technology whose efficacy and safety evidence in the short- and long-term (6 months to 5.8 years) is based on observational studies, most of which are descriptive; long-term results are currently the focus of research (cohort studies, RCTs) and are expected to be published in the next few years;
- the health professional-related, organizational, economic and ethical issues, including the patient's perspective, have been little examined in the published literature and merit an analysis in the Québec context;
- the S-ICD plays a role in the primary and secondary prevention of sudden arrhythmic cardiac death in carefully selected patients who meet criteria for ICD implantation but for whom cardiac stimulation and CRT are not indicated; and for whom a TV-ICD is contraindicated due to one or more of the following:
o difficult venous access or need to preserve venous access;
o the patient has had a TV-ICD removed because of a complication;
o the patient is young and needs an ICD for the long term. This last indication is based on expert opinion.
The conclusions drawn from the scientific literature will serve as a basis for future recommendations, developed by experts in this field, regarding the use and replacement of implantable cardiac devices in Québec.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Cardio/INESSS_Evaluation_defibrillateur_cardiaque_impl_sonde_sous-cutanee.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Defibrillators, Implantable
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
©Gouvernement du Québec/Institut national d'excellence en santé et en services sociaux
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.